Methyl (E)-3-(p-tolyl)acrylate

Catalog No. :
ACRPGV904
CAS No. :
20754-20-5
Molecular Formula :
C11H12O2
Molecular Weight :
176.21

IUPAC Name:methyl (E)-3-(p-tolyl)acrylate

Methyl (E)-3-(p-tolyl)acrylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g95%$87.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl (E)-3-(p-tolyl)acrylate
IUPAC Namemethyl (E)-3-(p-tolyl)acrylate
MDL No.MFCD00460746
Molecular FormulaC11H12O2
Molecular Weight176.21
SMILESO=C(OC)/C=C/C1=CC=C(C)C=C1
InChI KeyWLJBRXRCJNSDHT-BQYQJAHWSA-N
Synonym20754-20-5 | METHYL 4-METHYLCINNAMATE | Methyl 3-(p-tolyl)acrylate | 7560-43-2 | methyl (E)-3-(4-methylphenyl)prop-2-enoate | 2-Propenoic acid, 3-(4-methylphenyl)-, methyl ester, (2E)- | Methyl (2E)-3-(4-methylphenyl)prop-2-enoate | methyl 3-(4-methylphenyl)acrylate | 2-
CAS No.20754-20-5
PubChem CID5314312

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H317-H412
Precautionary Statement(s)
P261-P272-P273-P280-P302+P352-P312-P333+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACRPGV904 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCSAO480 route compound structure diagram
    ACCSAO48021204-67-1 In Stock
  2. Plus
  3. ACKOVF910 route compound structure diagram
    ACKOVF910104-87-0 In Stock
  4. Then
  5. ACRPGV904 route product structure diagram
    ACRPGV90420754-20-5 In Stock
Inquiry

2. ACRPGV904 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCSAO480 route compound structure diagram
    ACCSAO48021204-67-1 In Stock
  2. Plus
  3. ACKOVF910 route compound structure diagram
    ACKOVF910104-87-0 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACRPGV904 route product structure diagram
    ACRPGV90420754-20-5 In Stock
Inquiry

Comments (0)